SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yang Wang, Rong Fan, Jiekun Luo, Tao Tang, Zhihua Xing, Zian Xia, Weijun Peng, Wenzhu Wang, Huiying Lv, Wei Huang, Yizeng Liang, Lunzhao Yi, Hongmei Lu, Xi Huang, An ultra high performance liquid chromatography with tandem mass spectrometry method for plasma and cerebrospinal fluid pharmacokinetics of rhein in patients with traumatic brain injury after administration of rhubarb decoction, Journal of Separation Science, 2015, 38, 7
  2. 2
    Krista M. Rodgers, Yuetiva K. Deming, Florencia M. Bercum, Serhiy Y. Chumachenko, Julie L. Wieseler, Kirk W. Johnson, Linda R. Watkins, Daniel S. Barth, Reversal of Established Traumatic Brain Injury-Induced, Anxiety-Like Behavior in Rats after Delayed, Post-Injury Neuroimmune Suppression, Journal of Neurotrauma, 2014, 31, 5, 487

    CrossRef

  3. 3
    M. V. Padma Srivastava, Ashu Bhasin, Rama Chaudhry, Sakshi Sharma, S. Vivekanandhan, Rohit Bhatia, Manjari Tripathi, Role of Interleukin-6 Correlated toC. pneumoniaeInfection as a Biomarker for Prediction of Stroke Severity in Young Patients with Acute Ischemic Stroke, Asian Journal of Neuroscience, 2014, 2014, 1

    CrossRef

  4. 4
    Krista M. Rodgers, Florencia M. Bercum, Danielle L. McCallum, Jerry W. Rudy, Lauren C. Frey, Kirk W. Johnson, Linda R. Watkins, Daniel S. Barth, Acute Neuroimmune Modulation Attenuates the Development of Anxiety-Like Freezing Behavior in an Animal Model of Traumatic Brain Injury, Journal of Neurotrauma, 2012, 29, 10, 1886

    CrossRef

  5. 5
    Liang Zhao, Elizabeth Y. Shang, Chandrahas G. Sahajwalla, Application of pharmacokinetics–pharmacodynamics/clinical response modeling and simulation for biologics drug development, Journal of Pharmaceutical Sciences, 2012, 101, 12
  6. 6
    Kathleen A. Stuller, Brant Jarrett, A. Courtney DeVries, Stress and social isolation increase vulnerability to stroke, Experimental Neurology, 2012, 233, 1, 33

    CrossRef

  7. 7
    C Cawthorne, C Prenant, A Smigova, P Julyan, R Maroy, K Herholz, N Rothwell, H Boutin, Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [18F]-IL1RA and PET imaging in rats, British Journal of Pharmacology, 2011, 162, 3
  8. 8
    Adam Denes, Emmanuel Pinteaux, Nancy J. Rothwell, Stuart M. Allan, Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target, Cerebrovascular Diseases, 2011, 32, 6, 517

    CrossRef

  9. 9
    James Galea, Kayode Ogungbenro, Sharon Hulme, Andrew Greenhalgh, Leon Aarons, Sylvia Scarth, Peter Hutchinson, Samantha Grainger, Andrew King, Stephen J Hopkins, Nancy Rothwell, Pippa Tyrrell, Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study, Journal of Cerebral Blood Flow & Metabolism, 2011, 31, 2, 439

    CrossRef

  10. 10
    Dongyang Liu, Hoi-Kei Lon, Debra C. DuBois, Richard R. Almon, William J. Jusko, Population pharmacokinetic–pharmacodynamic–disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis, Journal of Pharmacokinetics and Pharmacodynamics, 2011, 38, 6, 769

    CrossRef

  11. 11
    Andrew D Greenhalgh, Kayode Ogungbenro, Nancy J Rothwell, James P Galea, Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 6, 681

    CrossRef

  12. 12
    J. W. M. van der Meer, A. Simon, Blocking IL-1  to slow down progression of ALS?, Proceedings of the National Academy of Sciences, 2010, 107, 29, 12741

    CrossRef

  13. 13
    T. Janowitz, D. K. Menon, Exploring New Routes for Neuroprotective Drug Development in Traumatic Brain Injury, Science Translational Medicine, 2010, 2, 27, 27rv1

    CrossRef

  14. 14
    Torben Glatz, Ivonne Stöck, Miriam Nguyen-Ngoc, Peter Gohlke, Thomas Herdegen, Juraj Culman, Yi Zhao, Peroxisome-proliferator-activated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain, Journal of Hypertension, 2010, 28, 7, 1488

    CrossRef

  15. 15
    AD Greenhalgh, J Galea, A Dénes, PJ Tyrrell, NJ Rothwell, Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection, British Journal of Pharmacology, 2010, 160, 1
  16. 16
    Elizabeth Fox, Nalini Jayaprakash, Tuyet-Hang Pham, Ayana Rowley, Cynthia L. McCully, Frank Pucino, Raphaela Goldbach-Mansky, The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates, Journal of Neuroimmunology, 2010, 223, 1-2, 138

    CrossRef

  17. 17
    Diana Amantea, Giuseppe Nappi, Giorgio Bernardi, Giacinto Bagetta, Maria T. Corasaniti, Post-ischemic brain damage: pathophysiology and role of inflammatory mediators, FEBS Journal, 2009, 276, 1
  18. 18
    RA Skinner, RM Gibson, NJ Rothwell, E Pinteaux, JI Penny, Transport of interleukin-1 across cerebromicrovascular endothelial cells, British Journal of Pharmacology, 2009, 156, 7
  19. 19
    Erratum, British Journal of Clinical Pharmacology, 2008, 66, 5
  20. 20
    J. M. Ritter, Pharmacokinetic(s) matters: stroke treatment et cetera., British Journal of Clinical Pharmacology, 2008, 65, 3